Pathological changes in a diseased site are often accompanied by abnormal activities of
various biomolecules in and around the involved cells. Identifying the location and …

Persistent androgen receptor (AR) signalling is the main driver of prostate cancer (PCa).
Truncated isoforms of the AR called androgen receptor variants (AR-Vs) lacking the ligand …

Four cardiac hormones, namely atrial natriuretic peptide, vessel dilator, kaliuretic peptide,
and long-acting natriuretic peptide, reduce up to 97% of all cancer cells in vitro. These four …

The natriuretic peptide family (NPs) is a group of natural endocrine hormones, containing a
17-amino acid ring structure connected by disulfide bonds of two cysteines. In this review …

SUMMARY 1 Cardiac natriuretic peptides consist of a family of six peptide hormones that
are synthesised by three separate genes and then stored as three separate prohormones (ie …

Atrial natriuretic peptide has been recently discovered to have anticancer effects via
interaction with cell surface natriuretic peptide receptor A (NPRA) and natriuretic peptide …

Background: Four cardiac hormones have anticancer effects in vitro: i) atrial natriuretic
peptide (ANP), ii) vessel dilator, iii) long acting natriuretic peptide (LANP), and iv) kaliuretic …

Background Mortality from renal‐cell cancer remains a significant problem with an estimated
12 600 deaths in the United States in 2005 even with current treatment (s) of surgery …

How the function of the JMJD2D epigenetic regulator is regulated or whether it plays a role
in prostate cancer has remained elusive. We found that JMJD2D was overexpressed in …

Background: Four cardiac hormones ie atrial natriuretic peptide (ANP), vessel dilator, long
acting natriuretic peptide (LANP) and kaliuretic peptide have anticancer effects in vitro …